{"id":"parestat-generic-parecoxib","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Injection site reactions"}]},"_chembl":{"chemblId":"CHEMBL1206690","moleculeType":"Small molecule","molecularWeight":"370.43"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Parecoxib selectively inhibits cyclooxygenase-2 (COX-2), an enzyme responsible for producing pro-inflammatory prostaglandins. By blocking COX-2 while sparing COX-1, it provides pain relief and reduces inflammation with potentially fewer gastrointestinal side effects compared to non-selective NSAIDs. It is administered intravenously or intramuscularly, making it suitable for acute postoperative pain management.","oneSentence":"Parecoxib is a selective COX-2 inhibitor that reduces prostaglandin production to provide anti-inflammatory and analgesic effects.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:59:43.156Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute postoperative pain management"},{"name":"Perioperative pain relief"}]},"trialDetails":[{"nctId":"NCT07154446","phase":"PHASE4","title":"Study Comparing Dynastat and Parestat Pain Relief Medications for Patients After Breast Surgery","status":"NOT_YET_RECRUITING","sponsor":"University of Malaya","startDate":"2025-10-01","conditions":"Breast Exicision Biopsy","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":144,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Parestat(generic parecoxib)","genericName":"Parestat(generic parecoxib)","companyName":"University of Malaya","companyId":"university-of-malaya","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Parecoxib is a selective COX-2 inhibitor that reduces prostaglandin production to provide anti-inflammatory and analgesic effects. Used for Acute postoperative pain, Perioperative pain management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}